The relationship between a poor prognosis and high levels of HDAC9 expression in B-cell precursor ALL patients was confirmed by Vega-García et al. [112], who analyzed mRNA expression levels in cells from pediatric patients diagnosed with acute leukemia. The gene discussed is HDAC9; the disease is acute lymphoblastic leukemia.